N-Acetyl Cysteine (NAC) Figures

43 figures issues de recherches évaluées par des pairs

Tous Psyllium Husk Bifidobacterium lactis Fructooligosaccharides (FOS) Lactobacillus plantarum Peppermint Oil Pancreatic Enzymes (Pancrelipase) Curcumin Vitamin A Medium-Chain Triglycerides (MCT Oil) Galactooligosaccharides (GOS) Lactobacillus gasseri Aloe Vera (Inner Leaf Gel) Alpha-Galactosidase Vitamin D L-Glutamine Inulin Ginger Lactase Berberine Omega-3 Fatty Acids (EPA/DHA) Bovine Colostrum Zinc Bifidobacterium bifidum Butyrate (Sodium/Calcium Butyrate) Bacillus coagulans Saccharomyces boulardii Lactobacillus acidophilus N-Acetyl Cysteine (NAC) Bifidobacterium longum

All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other

Figure 11

Figure 7 Histological examination of the safety of selenium-containing amino acids. Lung, kidney, heart, liver, and spleen tissues were collected, H&E stained, and analyzed for the safety profile of selenium-containing …

Selenium-Containing Amino Acids Protect Dextran Sulfate Sodium-Induced Colitis via Ameliorating Oxidative Stress …

Figure 6 Micrograph

Immunofluorescence imaging of Ku70/Ku80 localization in gastric epithelial cells, showing nuclear protein retention in alpha-lipoic acid-treated cells despite H. pylori infection.

α-Lipoic Acid Inhibits Apoptosis by Suppressing the Loss of Ku Proteins in …

Figure 7 Chart

Quantification of DNA double-strand break repair efficiency in H. pylori-infected gastric cells, indicating that alpha-lipoic acid supports the Ku-dependent non-homologous end joining pathway.

α-Lipoic Acid Inhibits Apoptosis by Suppressing the Loss of Ku Proteins in …

Figure 8 Chart

Cell viability analysis across different alpha-lipoic acid concentrations in H. pylori-infected gastric epithelial cells, establishing the effective dose range for cytoprotection.

α-Lipoic Acid Inhibits Apoptosis by Suppressing the Loss of Ku Proteins in …

Figure 9 Diagram

Signaling pathway analysis showing the molecular mechanism by which alpha-lipoic acid preserves Ku protein levels and inhibits apoptosis in H. pylori-infected gastric cells.

α-Lipoic Acid Inhibits Apoptosis by Suppressing the Loss of Ku Proteins in …

Figure 2 Micrograph

Liver histopathology from colitis-induced mice with and without oral NAC supplementation, evaluating extraintestinal hepatic manifestations including steatosis and inflammatory infiltration.

Extraintestinal Manifestations in Induced Colitis: Controversial Effects of N-Acetylcysteine on Colon, Liver, …

Figure 3 Micrograph

Kidney tissue histology showing renal changes associated with induced colitis, and the effects of N-acetylcysteine on renal inflammation and oxidative damage markers.

Extraintestinal Manifestations in Induced Colitis: Controversial Effects of N-Acetylcysteine on Colon, Liver, …

Figure 4 Chart

Oxidative stress biomarkers measured in colon, liver, and kidney tissues, comparing malondialdehyde (MDA) and glutathione (GSH) levels across treatment groups.

Extraintestinal Manifestations in Induced Colitis: Controversial Effects of N-Acetylcysteine on Colon, Liver, …

Figure 5 Chart

Inflammatory cytokine levels (such as TNF-alpha, IL-6, or IL-1beta) in colonic and extraintestinal tissues, assessing whether NAC modulates systemic inflammation originating from the gut.

Extraintestinal Manifestations in Induced Colitis: Controversial Effects of N-Acetylcysteine on Colon, Liver, …

Figure 6 Chart

Colon length measurements and macroscopic damage scoring in the colitis model, providing gross anatomical evidence of disease severity and NAC treatment response.

Extraintestinal Manifestations in Induced Colitis: Controversial Effects of N-Acetylcysteine on Colon, Liver, …

Figure 7 Chart

Summary of controversial findings regarding NAC's differential effects across organs, with protective trends observed in some tissues but potential adverse signals in others.

Extraintestinal Manifestations in Induced Colitis: Controversial Effects of N-Acetylcysteine on Colon, Liver, …

Figure 2

Scheme 1.Flowchart 1:The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).The coding for mucopenetrative liposomal formulation compositions (MP1-MP6).